| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/10/2000 | EP0998459A2 Pyridine derivatives |
| 05/10/2000 | EP0998454A2 Metalloproteinase inhibitors |
| 05/10/2000 | EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 05/10/2000 | CN1252720A Gastric-retained pharmaceutical compositions |
| 05/09/2000 | US6060479 Quinazoline-4-one AMPA antagonists |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/04/2000 | WO1999062879A8 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 05/04/2000 | DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use |
| 05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 05/02/2000 | US6057306 Method of treating the navicular disease in horses |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023076A1 Aminophenoxyacetic acid derivatives as neuroprotectants |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000004895A3 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | CN1251573A Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 04/25/2000 | US6054588 Heterocyclic vinyl ethers |
| 04/25/2000 | US6054444 Inhibit n-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme activity |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/18/2000 | US6051608 Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 04/18/2000 | CA1340960C Chroman derivatives |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020025A2 Akt compositions for enhancing survival of cells |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
| 04/12/2000 | EP0992492A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018753A1 2-phenylpyran-4-one derivatives |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO1999062505A3 Method for treating neurodegenerative disorders |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
| 04/05/2000 | EP0989850A1 Use of pramipexole in the treatment of restless legs syndrome |
| 04/05/2000 | EP0738147B1 Application of riluzole in the treatment of mitochondrial diseases |
| 04/04/2000 | US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 04/04/2000 | US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017358A2 Human chaperone proteins |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | WO2000016777A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 03/30/2000 | WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344670A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/30/2000 | CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/28/2000 | US6043251 Treating muscular and nervous system disorders; including an effective amount of 2-amino-6-trifluoromethoxybenzothiazole |
| 03/23/2000 | WO2000015806A1 Atp synthase subunit homolog |
| 03/23/2000 | WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
| 03/23/2000 | WO2000015793A2 Human gpcr proteins |
| 03/23/2000 | WO2000015609A1 Azetidine derivatives, preparation and medicines containing them |
| 03/23/2000 | WO2000015245A2 Stable liquid formulations of botulinum toxin |
| 03/23/2000 | WO2000015216A1 Therapeutic compositions (ii) |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2706859A1 Mammalian transforming growth factor beta - 9 |
| 03/23/2000 | CA2343838A1 Atp synthase subunit homolog |
| 03/23/2000 | CA2342833A1 Human gpcr proteins |
| 03/23/2000 | CA2342301A1 Human cell junction pdz protein |